Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 03, 2026 08:30 ET | Source: IN8bio, Inc

IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies

IN8bio Announces Publication in Nature Communications Highlighting Advances in Gamma-Delta T Cell Engineering and Combination Therapies
June 01, 2026 08:30 ET | Source: IN8bio, Inc

IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026

IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026
May 14, 2026 08:00 ET | Source: IN8bio, Inc

IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma

IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma
May 07, 2026 16:30 ET | Source: IN8bio, Inc

IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights

IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 06, 2026 08:00 ET | Source: IN8bio, Inc

IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences

IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
April 03, 2026 16:00 ET | Source: IN8bio, Inc

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 12, 2026 16:01 ET | Source: IN8bio, Inc

IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results - Highlights Durable Survival Improvements in Glioblastoma, Advancing Pipeline and Strengthened Financial Position for 2026

IN8bio Reports Fourth Quarter and Full-Year 2025 Financial Results
February 24, 2026 08:00 ET | Source: IN8bio, Inc

IN8bio to Present at TD Cowen 46th Annual Health Care Conference

IN8bio to Present at TD Cowen 46th Annual Health Care Conference
February 09, 2026 08:00 ET | Source: IN8bio, Inc

IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer

IN8bio Promotes Kate Rochlin, Ph.D., to President and Chief Operating Officer
February 03, 2026 08:00 ET | Source: IN8bio, Inc

IN8bio to Present at Upcoming Investor and Scientific Conferences in February

IN8bio to Present at Upcoming Investor and Scientific Conferences in February